← All organizations
Highest phase reached
Phase 4
First clinical trial
Sep 1, 2000Last known activity
Nov 1, 2019
Timeline
1940s
- Jan 1, 1946
National Institute of Nursing Research (NINR)— Founded
Drugs by trial phase (30 distinct, 31 trials)
Phase 4 (2 own, 0 via acquisition)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (19 own, 0 via acquisition)
Phase 1 (2 own, 0 via acquisition)
Other trials (6 own, 0 via acquisition)
Indications
Studied for
- Acute Pain
- Asthma
- Brain Injuries
- Brain Injuries, Traumatic
- Causalgia
- Chronic Pain
- Complex Regional Pain Syndromes
- Depression
- Diabetes Mellitus
- Dyspnea
- Fatigue
- Fibromyalgia
- Graft vs Host Disease
- Hepatitis
- Hepatitis A
- Hepatitis C
- Irritable Bowel Syndrome
- Leukemia
- Muscular Diseases
- Myofascial Pain Syndromes
- Neoplasms
- Neuralgia
- Neuromuscular Diseases
- Prostatic Neoplasms
- Recurrence
- Reflex Sympathetic Dystrophy
- Respiratory Insufficiency
- Sleep Initiation and Maintenance Disorders
- Sleep Wake Disorders
- Somatoform Disorders
- Stomatitis
- Syndrome
- Wounds and Injuries
Recent trials (38)
- NCT04119037CollaboratorPhase 3Nov 1, 2019
- NCT04141696Lead sponsorPhase 1/Phase 2Oct 31, 2019
- NCT04141696Overall official - principal investigatorPhase 1/Phase 2Oct 31, 2019
- NCT04002362CollaboratorPhase 2Oct 1, 2019
- NCT03730194CollaboratorN/AMay 31, 2019
- NCT02577120CollaboratorPhase 4Jan 9, 2019
- NCT04036110CollaboratorN/AAug 14, 2018
- NCT02931474Lead sponsorPhase 2Oct 6, 2016
- NCT02931474Overall official - principal investigatorPhase 2Oct 6, 2016
- NCT02499497CollaboratorPhase 2Jul 1, 2015
- NCT02362425Overall official - principal investigatorPhase 1/Phase 2Jan 21, 2015
- NCT02362425Lead sponsorPhase 1/Phase 2Jan 21, 2015
- NCT02317341Overall official - principal investigatorEarly Phase 1Dec 2, 2014
- NCT02317341Lead sponsorEarly Phase 1Dec 2, 2014
- NCT02524054CollaboratorPhase 1/Phase 2Nov 1, 2014
Details
- Founded
- Bethesda, MD, US Jan 1, 1946
- Last known activity
- Nov 1, 2019